ABCC1 and acute myeloid leukemia: Since the expression levels of MDR1 (ABCB1) and MRP1 (ABCC1) (39–41) transporter pumps regulate the anti-leukemic effects of GO by influencing the intracellular accumulation of calicheamicin, these transporter pumps play a critical role in drug resistance of AML.